Solutions
- - Healthcare Professionals
  - - H1 Connect
      
      Connecting Doctors and NGOs to empower medical missions and humanitarian work worldwide.
      
      Learn more
How We Help
- - By Customer
  - Pharmaceutical & Biotechnology
  - Payors
  - Healthcare Professionals
- - Featured
  - - Empowering Medical and Commercial Teams with Data Insights
      
      In Conversation with Katie Shin, Sr. Global Director of Field Medical and Scientific Affairs, Sumitomo Pharma America
      
      Learn More
Customers
Resources
Company
- - What’s New
  - Press
  - Events
  - Get in Touch
  - Contact Us
- - Featured Press
  - - H1 Expands Trial Landscape with U.K. Diversity Data to Enhance Clinical Trial Equity and Meet Evolving Regulatory Standards
      
      Learn More
Request a Demo
Login

Request a Demo Login

Blog

Read the latest perspectives from our team of subject matter experts and others

doctor speaking with patient

FDA Poised to Make Impact on Underrepresented Populations in Clinical Studies

Diversity Action Plans (DAPs) aim to improve data that the FDA receives by increasing the clinical enrollment of historically underrepresented participants. Increasing diversity in clinical trials not only makes the… Continue reading →

Read the article

Post Topics:

Artificial Intelligence

Commercialization

Diversity & Inclusion

Drug Development

Global Impact

HCP Volunteers

KOL Engagement

Provider Data

Research

Post Industries:

Commercialization

Global Impact

Payors

Pharmaceutical & Biotechnology

Provider Data

Research

KOL Engagement
Educating Physicians to Improve the Patient Diagnostic Journey
The best diagnostic journey for a patient is the shortest. The less time is lost between a patient seeing a healthcare provider for the first time for their symptoms… Continue reading →

Read the article
no
KOL Engagement
Dr. Sekar Kathiresan’s Impact on Cardiology
Scholarly Influence Publications Dr. Kathiresan is a cardiologist and the CEO of Verve Therapeutics, a company that works on gene editing medicine for cardiovascular disease. Additionally, he is… Continue reading →

Read the article
KOL Engagement
The Term KOL: Keep It or Ditch It?
Listening to webinars and reading reports about the latest trends and developments in medical affairs is one of the things we do incessantly at H1 – after all we need… Continue reading →

Read the article
KOL Engagement
The Power of Micro-Influencers in Healthcare
How can we break through the noise to reach healthcare providers and key opinion leaders with important information? Consistently engaging external experts has always been one of the main… Continue reading →

Read the article
KOL Engagement
Dr. Krishna Aragam’s Impact on Cardiology
Scholarly Influence Publications Dr. Aragam is a Rising Star and Preventive Cardiologist at Massachusetts General Hospital as well as an Instructor of Medicine at Harvard Medical School. According to… Continue reading →

Read the article
KOL Engagement
How to Engage the Payer Community
Even before COVID threw the entire healthcare ecosystem into disarray, payers as well as the healthcare market in general faced significant cost pressure. Healthcare payers reacted with consolidation and vertical… Continue reading →

Read the article

«‹10 11 121314 15 16 ›»

Creating a
Healthier Future

Platform

H1

Products

HCP Universe
Trial Landscape
Precise
H1 Connect

About

About H1
Culture
Press
Events
Join Our Team
Login

Contact

Contact Us
Product Support

Social

Facebook Twitter LinkedIn Instagram

© H1 2024 All Rights Reserved Terms of Use Privacy Policy

Welcome

Choose your account below to login.

HCP Universe
Trial Landscape

Don't have an account? Request a demo.

✕